Tattoli Mark Damian has filed 58 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 33490 shares of Core Laboratories Inc. /DE/ ($CLB) on February 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | A | Performance Shares | 33490 | $0.00 | 33,490.0000 | 47,381,000 | 9999.99% | 0.07% |
| Dec. 31, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 14310 | $16.03 | 29,075.4630 | 47,381,000 | 32.98% | 0.03% |
| Dec. 31, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Performance Shares | 24952 | $0.00 | 0.0000 | 47,381,000 | 100.00% | 0.05% |
| Dec. 31, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 24952 | $0.00 | 43,385.4630 | 47,381,000 | 135.36% | 0.05% |
| Oct. 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 700 | $0.00 | 1,450.0000 | 47,381,000 | 32.56% | 0.00% |
| Oct. 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 700 | $0.00 | 18,709.4630 | 47,381,000 | 3.89% | 0.00% |
| Oct. 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 276 | $12.58 | 18,433.4630 | 47,381,000 | 1.48% | 0.00% |
| Aug. 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 250 | $0.00 | 18,108.4630 | 47,685,000 | 1.40% | 0.00% |
| Aug. 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 99 | $10.53 | 18,009.4630 | 47,685,000 | 0.55% | 0.00% |
| Aug. 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 250 | $0.00 | 2,150.0000 | 47,685,000 | 10.42% | 0.00% |
| May 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 250 | $0.00 | 17,957.4630 | 47,685,000 | 1.41% | 0.00% |
| May 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 79 | $11.68 | 17,707.4630 | 47,685,000 | 0.44% | 0.00% |
| May 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 200 | $0.00 | 17,786.4630 | 47,685,000 | 1.14% | 0.00% |
| May 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 250 | $0.00 | 2,400.0000 | 47,685,000 | 9.43% | 0.00% |
| May 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 200 | $0.00 | 2,650.0000 | 47,685,000 | 7.02% | 0.00% |
| May 1, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 99 | $11.68 | 17,858.4630 | 47,685,000 | 0.55% | 0.00% |
| Feb. 13, 2025 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | A | Performance Shares | 32912 | $0.00 | 32,912.0000 | 47,685,000 | 9999.99% | 0.07% |
| Dec. 31, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 5028 | $17.31 | 17,586.4630 | 47,820,000 | 22.23% | 0.01% |
| Dec. 31, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 9604 | $0.00 | 22,614.4630 | 47,820,000 | 73.82% | 0.02% |
| Dec. 31, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Performance Shares | 9604 | $0.00 | 0.0000 | 47,820,000 | 100.00% | 0.02% |
| Oct. 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 276 | $19.21 | 13,010.4630 | 47,820,000 | 2.08% | 0.00% |
| Oct. 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 700 | $0.00 | 13,286.4630 | 47,820,000 | 5.56% | 0.00% |
| Oct. 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 700 | $0.00 | 2,850.0000 | 47,820,000 | 19.72% | 0.00% |
| Aug. 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 99 | $23.24 | 12,586.4630 | 47,523,000 | 0.78% | 0.00% |
| Aug. 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 250 | $0.00 | 12,685.4630 | 47,523,000 | 2.01% | 0.00% |
| Aug. 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 48 | $23.24 | 12,435.4630 | 47,523,000 | 0.38% | 0.00% |
| Aug. 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 120 | $0.00 | 12,483.4630 | 47,523,000 | 0.97% | 0.00% |
| Aug. 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 250 | $0.00 | 3,550.0000 | 47,523,000 | 6.58% | 0.00% |
| Aug. 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 120 | $0.00 | 3,800.0000 | 47,523,000 | 3.06% | 0.00% |
| May 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 200 | $0.00 | 12,291.4630 | 47,523,000 | 1.65% | 0.00% |
| May 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 200 | $0.00 | 4,170.0000 | 47,523,000 | 4.58% | 0.00% |
| May 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 250 | $0.00 | 3,920.0000 | 47,523,000 | 6.00% | 0.00% |
| May 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 99 | $15.71 | 12,363.4630 | 47,523,000 | 0.79% | 0.00% |
| May 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 79 | $15.71 | 12,212.4630 | 47,523,000 | 0.64% | 0.00% |
| May 1, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 250 | $0.00 | 12,462.4630 | 47,523,000 | 2.05% | 0.00% |
| Feb. 15, 2024 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | A | Performance Shares | 38002 | $0.00 | 38,002.0000 | 47,523,000 | 9999.99% | 0.08% |
| Dec. 31, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 2716 | $17.66 | 10,376.6210 | 46,813,000 | 20.74% | 0.01% |
| Dec. 29, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Performance Shares | 6900 | $0.00 | 0.0000 | 46,813,000 | 100.00% | 0.01% |
| Dec. 31, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 6900 | $0.00 | 14,807.4630 | 46,813,000 | 87.26% | 0.01% |
| Dec. 31, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 2654 | $17.66 | 12,153.4630 | 46,813,000 | 17.92% | 0.01% |
| Dec. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 160 | $0.00 | 7,969.4630 | 46,813,000 | 2.05% | 0.00% |
| Dec. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 160 | $0.00 | 4,370.0000 | 46,813,000 | 3.53% | 0.00% |
| Dec. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 62 | $18.07 | 7,907.4630 | 46,813,000 | 0.78% | 0.00% |
| Oct. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 700 | $0.00 | 8,079.4630 | 46,813,000 | 9.49% | 0.00% |
| Oct. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 700 | $0.00 | 4,530.0000 | 46,813,000 | 13.38% | 0.00% |
| Oct. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 270 | $24.01 | 7,809.4630 | 46,813,000 | 3.34% | 0.00% |
| Aug. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 120 | $0.00 | 5,480.0000 | 46,813,000 | 2.14% | 0.00% |
| Aug. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 250 | $0.00 | 5,230.0000 | 46,813,000 | 4.56% | 0.00% |
| Aug. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 120 | $0.00 | 7,276.4630 | 46,813,000 | 1.68% | 0.00% |
| Aug. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 47 | $27.43 | 7,229.4630 | 46,813,000 | 0.65% | 0.00% |
| Aug. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 250 | $0.00 | 7,479.4630 | 46,813,000 | 3.46% | 0.00% |
| Aug. 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 100 | $27.43 | 7,379.4630 | 46,813,000 | 1.34% | 0.00% |
| May 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 97 | $22.03 | 7,156.4630 | 46,813,000 | 1.34% | 0.00% |
| May 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | Common Stock | 77 | $22.03 | 7,003.4630 | 46,813,000 | 1.09% | 0.00% |
| May 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 200 | $0.00 | 7,080.4630 | 46,813,000 | 2.91% | 0.00% |
| May 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 250 | $0.00 | 5,600.0000 | 46,813,000 | 4.27% | 0.00% |
| May 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Restricted Shares | 200 | $0.00 | 5,850.0000 | 46,813,000 | 3.31% | 0.00% |
| May 1, 2023 | Core Laboratories Inc. /DE/ | $CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | Common Stock | 250 | $0.00 | 7,253.4630 | 46,813,000 | 3.57% | 0.00% |